Prognostic values of B7-H4 in non-small cell lung cancer.
The aim of this study was to explore the prognostic value of serum soluble B7-H4 (sB7-H4) levels in patients with non-small cell lung cancer (NSCLC). Serum specimens from 316 NSCLC patients and 240 healthy controls were collected. The concentrations of sB7-H4 were measured by ELISA. The levels of sB7-H4 in NSCLC patients were significantly higher than that of the controls (P<0.01). Multivariate survival analysis indicated that sB7-H4 was an independent prognostic indicator of overall survival and progression-free survival (P<0.01). Measurement of serum sB7-H4 might be a useful prognostic biomarker for NSCLC.